Anne Doye Selected Research

Nigericin

1/2021

Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Doye Research Topics

Disease

5	Neoplasms (Cancer) 01/2017 - 10/2005
2	Communicable Diseases (Infectious Diseases) 01/2021 - 02/2011
1	COVID-19 01/2021
1	Infections 01/2021
1	Inflammation (Inflammations) 01/2021
1	Rupture 11/2011
1	Edema (Dropsy) 11/2011
1	Peptic Ulcer (Peptic Ulcers) 10/2005

Drug/Important Bio-Agent (IBA)

2	InflammasomesIBA 01/2021 - 01/2021
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017 - 11/2011
2	Proteins (Proteins, Gene)FDA Link 05/2008 - 06/2006
1	Pattern Recognition ReceptorsIBA 01/2021
1	NigericinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Monomeric GTP-Binding ProteinsIBA 01/2017
1	Cyclic AMP (AMP, Cyclic)IBA 11/2011
1	Bacterial ToxinsIBA 11/2011
1	Biological Control AgentsIBA 02/2011
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2008
1	Virulence Factors (Pathogenicity Factors)IBA 10/2005
1	Cytotoxins (Cytolysins)IBA 10/2005